Trials / Completed
CompletedNCT02576860
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea With a 4 Week Follow-up Period
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 263 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the safety and efficacy of once-daily application of CLS001 topical gel compared to vehicle gel in subjects with severe papulopustular rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CLS001 (Omiganan) | Topical gel |
| DRUG | Vehicle | Vehicle gel |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-02-27
- Completion
- 2017-09-05
- First posted
- 2015-10-15
- Last updated
- 2022-08-02
- Results posted
- 2022-07-08
Locations
47 sites across 9 countries: United States, Australia, Canada, France, Germany, Netherlands, New Zealand, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT02576860. Inclusion in this directory is not an endorsement.